Search research articles
Contact Us
Filters
Showing results (11-20 of 39) with videos related to
Page
of 4
Sort By:
Virology Journal
|
November 20, 2016
Annexin A2 antibodies but not inhibitors of the annexin A2 heterotetramer impair productive HIV-1 infection of macrophages in vitro
Andrew W Woodham, Adriana M Sanna, Julia R Taylor, et al.
Virology
|
March 11, 2014
Suppression of Langerhans cell activation is conserved amongst human papillomavirus α and β genotypes, but not a µ genotype
Diane M Da Silva, Carly A Movius, Adam B Raff, et al.
Vaccine
|
April 24, 2019
Therapeutic efficacy of a human papillomavirus type 16 E7 bacterial exotoxin fusion protein adjuvanted with CpG or GPI-0100 in a preclinical mouse model for HPV-associated disease
Diane M Da Silva, Joseph G Skeate, Elena Chavez-Juan, et al.
Journal of Virology
|
March 29, 2013
The evolving field of human papillomavirus receptor research: a review of binding and entry
Adam B Raff, Andrew W Woodham, Laura M Raff, et al.
Scientific Reports
|
August 5, 2018
Heterotetrameric annexin A2/S100A10 (A2t) is essential for oncogenic human papillomavirus trafficking and capsid disassembly, and protects virions from lysosomal degradation
Julia R Taylor, Daniel J Fernandez, Shantaé M Thornton, et al.
The Journal of Antimicrobial Chemotherapy
|
February 26, 2015
Small molecule inhibitors of the annexin A2 heterotetramer prevent human papillomavirus type 16 infection
Andrew W Woodham, Julia R Taylor, Andrew I Jimenez, et al.
Cells
|
April 25, 2020
The Essential Role of anxA2 in Langerhans Cell Birbeck Granules Formation
Shantae M Thornton, Varsha D Samararatne, Joseph G Skeate, et al.
The Prostate
|
November 18, 2014
Forced LIGHT expression in prostate tumors overcomes Treg mediated immunosuppression and synergizes with a prostate tumor therapeutic vaccine by recruiting effector T lymphocytes
Lisa Yan, Diane M Da Silva, Bhavna Verma, et al.
Papillomavirus Research (Amsterdam, Netherlands)
|
May 17, 2016
T cell ignorance is bliss: T cells are not tolerized by Langerhans cells presenting human papillomavirus antigens in the absence of costimulation
Andrew W Woodham, Lisa Yan, Joseph G Skeate, et al.
Frontiers in Immunology
|
November 6, 2020
Theta-Defensins Inhibit High-Risk Human Papillomavirus Infection Through Charge-Driven Capsid Clustering
Joseph G Skeate, Wouter H Segerink, Mauricio D Garcia, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 39) with videos related to
Sort By:
Page
of 4
Virology Journal
|
November 20, 2016
Annexin A2 antibodies but not inhibitors of the annexin A2 heterotetramer impair productive HIV-1 infection of macrophages in vitro
Andrew W Woodham, Adriana M Sanna, Julia R Taylor, et al.
Virology
|
March 11, 2014
Suppression of Langerhans cell activation is conserved amongst human papillomavirus α and β genotypes, but not a µ genotype
Diane M Da Silva, Carly A Movius, Adam B Raff, et al.
Vaccine
|
April 24, 2019
Therapeutic efficacy of a human papillomavirus type 16 E7 bacterial exotoxin fusion protein adjuvanted with CpG or GPI-0100 in a preclinical mouse model for HPV-associated disease
Diane M Da Silva, Joseph G Skeate, Elena Chavez-Juan, et al.
Journal of Virology
|
March 29, 2013
The evolving field of human papillomavirus receptor research: a review of binding and entry
Adam B Raff, Andrew W Woodham, Laura M Raff, et al.
Scientific Reports
|
August 5, 2018
Heterotetrameric annexin A2/S100A10 (A2t) is essential for oncogenic human papillomavirus trafficking and capsid disassembly, and protects virions from lysosomal degradation
Julia R Taylor, Daniel J Fernandez, Shantaé M Thornton, et al.
The Journal of Antimicrobial Chemotherapy
|
February 26, 2015
Small molecule inhibitors of the annexin A2 heterotetramer prevent human papillomavirus type 16 infection
Andrew W Woodham, Julia R Taylor, Andrew I Jimenez, et al.
Cells
|
April 25, 2020
The Essential Role of anxA2 in Langerhans Cell Birbeck Granules Formation
Shantae M Thornton, Varsha D Samararatne, Joseph G Skeate, et al.
The Prostate
|
November 18, 2014
Forced LIGHT expression in prostate tumors overcomes Treg mediated immunosuppression and synergizes with a prostate tumor therapeutic vaccine by recruiting effector T lymphocytes
Lisa Yan, Diane M Da Silva, Bhavna Verma, et al.
Papillomavirus Research (Amsterdam, Netherlands)
|
May 17, 2016
T cell ignorance is bliss: T cells are not tolerized by Langerhans cells presenting human papillomavirus antigens in the absence of costimulation
Andrew W Woodham, Lisa Yan, Joseph G Skeate, et al.
Frontiers in Immunology
|
November 6, 2020
Theta-Defensins Inhibit High-Risk Human Papillomavirus Infection Through Charge-Driven Capsid Clustering
Joseph G Skeate, Wouter H Segerink, Mauricio D Garcia, et al.
Page
of 4